Literature DB >> 1798824

Codistribution of a sensory gating deficit and schizophrenia in multi-affected families.

M C Waldo1, G Carey, M Myles-Worsley, E Cawthra, L E Adler, H T Nagamoto, P Wender, W Byerley, R Plaetke, R Freedman.   

Abstract

Because the clinical diagnosis of schizophrenia has not generally been an adequate phenotypic marker to detect the genes that convey risk for schizophrenia, efforts have been directed toward the identification of more elementary neuronal dysfunctions in schizophrenic patients and their families. Psychophysiological studies of sensory gating and selective attention suggest that defects in these brain functions are present in schizophrenic patients and some of their relatives. This study examines one of these defects in sensory gating, failure to suppress the P50 evoked response to repeated auditory stimuli. Six pedigrees, chosen because of the presence of large sibships containing several cases of schizophrenia, were studied. A mathematical model was developed to assess the familial association of the P50 defect with schizophrenia. The model preserves the quantitative nature of the data and is suitable for use in a sample with small numbers of pedigrees comprising many individuals. It is thus suitable for the evaluation of putative phenotypes in families to be studied by linkage analysis with polymorphic genetic markers. The results suggest that the P50 defect is familially associated with schizophrenia.

Entities:  

Mesh:

Year:  1991        PMID: 1798824     DOI: 10.1016/0165-1781(91)90092-4

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

Review 1.  Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.

Authors:  David Potter; Ann Summerfelt; James Gold; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

Review 2.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

3.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

Authors:  R Freedman; H Coon; M Myles-Worsley; A Orr-Urtreger; A Olincy; A Davis; M Polymeropoulos; J Holik; J Hopkins; M Hoff; J Rosenthal; M C Waldo; F Reimherr; P Wender; J Yaw; D A Young; C R Breese; C Adams; D Patterson; L E Adler; L Kruglyak; S Leonard; W Byerley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives.

Authors:  Mei-Hua Hall; Grantley Taylor; Dean F Salisbury; Deborah L Levy
Journal:  Schizophr Bull       Date:  2010-04-02       Impact factor: 9.306

Review 5.  Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Authors:  Ann Olincy; Robert Freedman
Journal:  Handb Exp Pharmacol       Date:  2012

6.  Attentional modulation of the P50 suppression deficit in recent-onset and chronic schizophrenia.

Authors:  Cindy M Yee; Terrance J Williams; Patricia M White; Keith H Nuechterlein; Donna Ames; Kenneth L Subotnik
Journal:  J Abnorm Psychol       Date:  2010-02

Review 7.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

8.  Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Authors:  Erin A Hazlett; Ethan G Rothstein; Rui Ferreira; Jeremy M Silverman; Larry J Siever; Ann Olincy
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

9.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 10.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.